Metraipolis › archive › dc_daaf511f97a0

Phase change nanodroplets: Challenges and clinical potential — Europe PMC PMID:42592310

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42592310
DOI: 10.1016/j.apsb.2026.05.030
License (as archived): solo-consultazione
Archived: 2026-11-01T05:12:27.114Z
SHA-256 of the archived text: 8e3413aa2ec014d585e7d4c118725720b032181526cf59a43bda1ce9a3137957
Stable URL of this page: https://metraipolis.com/documento/dc_daaf511f97a0

How to cite

Phase change nanodroplets: Challenges and clinical potential — Europe PMC PMID:42592310 — Europe PMC (en), https://europepmc.org/article/MED/42592310 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_daaf511f97a0 (Metraipolis archive dc_daaf511f97a0, sha256 8e3413aa2ec014d585e7d4c118725720b032181526cf59a43bda1ce9a3137957)

BibTeX

@misc{dcdaaf511f97a0,
  title = {Phase change nanodroplets: Challenges and clinical potential — Europe PMC PMID:42592310},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42592310},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_daaf511f97a0; sha256 8e3413aa2ec014d585e7d4c118725720b032181526cf59a43bda1ce9a3137957},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42592310. Agents can read the archived copy with the MCP tool read_document.